{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:43:02Z","timestamp":1791290582308,"version":"4.3.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":221,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Toxicology"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.crtox.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T14:31:41Z","timestamp":1629210701000},"page":"309-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Use of a rapid human primary cell-based disease screening model, to compare next generation products to combustible cigarettes"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0664-0693","authenticated-orcid":false,"given":"Liam","family":"Simms","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6308-7305","authenticated-orcid":false,"given":"Elizabeth","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5149-6665","authenticated-orcid":false,"given":"Ellen L.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9410-7276","authenticated-orcid":false,"given":"Fan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8498-2184","authenticated-orcid":false,"given":"Kathryn","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7591-2125","authenticated-orcid":false,"given":"Lukasz","family":"Czekala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Trelles Sticken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Brinster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Wieczorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1463-9406","authenticated-orcid":false,"given":"Matthew","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvir","family":"Walele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/aivt.2016.0025","article-title":"Nicotine quantification in vitro: a consistent dosimetry marker for e-cigarette aerosol and cigarette smoke generation","volume":"3","author":"Adamson","year":"2017","journal-title":"Appl. In Vitro Toxicol."},{"issue":"3","key":"10.1016\/j.crtox.2021.08.003_b0010","doi-asserted-by":"crossref","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","article-title":"Effects of tobacco smoke on immunity, inflammation and autoimmunity","volume":"34","author":"Arnson","year":"2010","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.crtox.2021.08.003_b0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3109\/08958378.2012.654857","article-title":"A lung dosimetry model of vapor uptake and tissue disposition","volume":"24","author":"Asgharian","year":"2012","journal-title":"Inhal. Toxicol."},{"issue":"43","key":"10.1016\/j.crtox.2021.08.003_b0020","doi-asserted-by":"crossref","first-page":"28944","DOI":"10.1074\/jbc.M800685200","article-title":"The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB","volume":"283","author":"Baglole","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.crtox.2021.08.003_b0025","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/721608","article-title":"The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis","volume":"2011","author":"Barnes","year":"2011","journal-title":"Int. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.crtox.2021.08.003_b0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/aivt.2018.0001","article-title":"Characterization of a Vitrocell VC1 using nicotine dosimetry: an essential component toward standardized in vitro aerosol exposure of tobacco and next generation nicotine delivery products","volume":"4","author":"Behrsing","year":"2018","journal-title":"Appl. In Vitro Toxicol."},{"key":"10.1016\/j.crtox.2021.08.003_b0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-540-69248-5_2","article-title":"Nicotine chemistry, metabolism, kinetics and biomarkers","volume":"192","author":"Benowitz","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.crtox.2021.08.003_b0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ddtec.2017.01.001","article-title":"Phenotypic chemical biology for predicting safety and efficacy","volume":"23","author":"Berg","year":"2017","journal-title":"Drug Discovery Today: Technol."},{"issue":"47","key":"10.1016\/j.crtox.2021.08.003_b0045","article-title":"Human cell-based in vitro phenotypic profiling for drug safety-related attrition","volume":"2","author":"Berg","year":"2019","journal-title":"Front. Big Data"},{"key":"10.1016\/j.crtox.2021.08.003_b0050","unstructured":"Berg, E.L., et al. Evaluation of EPA\u2019s ToxCast Data from the BioMAP\u00ae Platform for Human-Relevant Toxicity Signatures. 2019; Available from: https:\/\/www.discoverx.com\/tools-resources\/document-resource-library\/documents\/sot-2019-biomap-toxicology-poster."},{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0055","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/ijms16011008","article-title":"Elucidating mechanisms of toxicity using phenotypic data from primary human cell systems\u2013a chemical biology approach for thrombosis-related side effects","volume":"16","author":"Berg","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vascn.2009.10.001","article-title":"Chemical target and pathway toxicity mechanisms defined in primary human cell systems","volume":"61","author":"Berg","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"10","key":"10.1016\/j.crtox.2021.08.003_b0065","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1177\/1087057113505324","article-title":"Building predictive models for mechanism-of-action classification from phenotypic assay data sets","volume":"18","author":"Berg","year":"2013","journal-title":"J. Biomol. Screen."},{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0070","first-page":"48","article-title":"Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update","volume":"2","author":"Bethune","year":"2010","journal-title":"J. Thorac Dis."},{"key":"10.1016\/j.crtox.2021.08.003_b0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.yrtph.2017.07.032","article-title":"Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers","volume":"89","author":"Brossard","year":"2017","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.crtox.2021.08.003_b0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.talanta.2018.02.048","article-title":"Determination of eight carbonyl compounds in aerosols trapped in phosphate buffer saline solutions to support in vitro assessment studies","volume":"184","author":"Buratto","year":"2018","journal-title":"Talanta"},{"issue":"5","key":"10.1016\/j.crtox.2021.08.003_b0085","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1164\/rccm.200404-511OC","article-title":"Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse","volume":"170","author":"Churg","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.crtox.2021.08.003_b0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.yrtph.2019.01.036","article-title":"Toxicological comparison of cigarette smoke and e-cigarette aerosol using a 3D in vitro human respiratory model","volume":"103","author":"Czekala","year":"2019","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.crtox.2021.08.003_b0095","doi-asserted-by":"crossref","unstructured":"Czekala, L., et al., 2021, The in vitro ToxTracker and Aneugen Clastogen Evaluation extension assay as a tool in the assessment of relative genotoxic potential of e-liquids and their aerosols. Mutagenesis.","DOI":"10.1093\/mutage\/geaa033"},{"issue":"10","key":"10.1016\/j.crtox.2021.08.003_b0100","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.3390\/ijerph10105146","article-title":"Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells","volume":"10","author":"Farsalinos","year":"2013","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"4","key":"10.1016\/j.crtox.2021.08.003_b0105","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1535-7163.MCT-11-0698","article-title":"Cigarette smoke induces aberrant EGF receptor activation that mediates lung cancer development and resistance to tyrosine kinase inhibitors","volume":"11","author":"Filosto","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.crtox.2021.08.003_b0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yrtph.2018.09.016","article-title":"Accurate measurement of main aerosol constituents from heated tobacco products (HTPs): implications for a fundamentally different aerosol","volume":"99","author":"Gasparyan","year":"2018","journal-title":"Regul. Toxicol. Pharm."},{"issue":"2","key":"10.1016\/j.crtox.2021.08.003_b0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0034-5687(78)90104-4","article-title":"The normal human lung: ultrastructure and morphometric estimation of diffusion capacity","volume":"32","author":"Gehr","year":"1978","journal-title":"Respir. Physiol."},{"issue":"2","key":"10.1016\/j.crtox.2021.08.003_b0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/tobaccocontrol-2012-050859","article-title":"Levels of selected carcinogens and toxicants in vapour from electronic cigarettes","volume":"23","author":"Goniewicz","year":"2014","journal-title":"Tob Control"},{"issue":"3","key":"10.1016\/j.crtox.2021.08.003_b0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.14573\/altex.1606291","article-title":"E-cigarettes and the need and opportunities for alternatives to animal testing","volume":"33","author":"Hartung","year":"2016","journal-title":"Altex"},{"issue":"9","key":"10.1016\/j.crtox.2021.08.003_b0130","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1177\/1087057109345525","article-title":"Profiling bioactivity of the ToxCast chemical library using BioMAP primary human cell systems","volume":"14","author":"Houck","year":"2009","journal-title":"J. Biomol. Screen."},{"issue":"2 Suppl","key":"10.1016\/j.crtox.2021.08.003_b0135","first-page":"501","article-title":"The possible mechanisms of tumor progression via CSF-1\/CSF-1R pathway activation","volume":"55","author":"Huang","year":"2014","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.crtox.2021.08.003_b0140","unstructured":"Institute of Medicine, Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction, ed. K. Stratton, et al. 2001, Washington, DC: The National Academies Press. 656."},{"key":"10.1016\/j.crtox.2021.08.003_b0145","unstructured":"International Organization for Standardization, ISO 3402:1999, in Tobacco and tobacco products \u2014 Atmosphere for conditioning and testing. 1999: https:\/\/www.iso.org\/standard\/28324.html. p. 5."},{"key":"10.1016\/j.crtox.2021.08.003_b0150","unstructured":"ISO, I.O.f.S., ISO 21160:2018 Cigarettes \u2014 Determination of selected carbonyls in the mainstream smoke of cigarettes \u2014 Method using high performance liquid chromatography. 2018."},{"key":"10.1016\/j.crtox.2021.08.003_b0155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.toxrep.2019.02.009","article-title":"Mainstream smoke constituents and in vitro toxicity comparative analysis of 3R4F and 1R6F reference cigarettes","volume":"6","author":"Jaccard","year":"2019","journal-title":"Toxicol. Rep."},{"issue":"12","key":"10.1016\/j.crtox.2021.08.003_b0160","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1158\/1055-9965.EPI-09-0965","article-title":"Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco","volume":"18","author":"Johnson","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"6","key":"10.1016\/j.crtox.2021.08.003_b0165","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nbt.2914","article-title":"Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms","volume":"32","author":"Kleinstreuer","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"2\u20134","key":"10.1016\/j.crtox.2021.08.003_b0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10937404.2010.483176","article-title":"Toxicity testing in the 21st century: a vision and a strategy","volume":"13","author":"Krewski","year":"2010","journal-title":"J Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.crtox.2021.08.003_b0175","doi-asserted-by":"crossref","unstructured":"Li, X., et al., 2019, Chemical Analysis and Simulated Pyrolysis of Tobacco Heating System 2.2 Compared to Conventional Cigarettes. Nicotine Tob Res, 21(1): p. 111-118.","DOI":"10.1093\/ntr\/nty005"},{"issue":"3","key":"10.1016\/j.crtox.2021.08.003_b0180","doi-asserted-by":"crossref","first-page":"L391","DOI":"10.1152\/ajplung.00062.2005","article-title":"The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts","volume":"289","author":"Martey","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.crtox.2021.08.003_b0185","doi-asserted-by":"crossref","first-page":"S196","DOI":"10.1016\/j.toxlet.2013.05.455","article-title":"Systems biology approach reveals a dose-dependent recovery of primary human airway epithelium culture after exposure to cigarette smoke","volume":"221","author":"Mathis","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.crtox.2021.08.003_b0190","unstructured":"A, M., et al. E-cigarettes: an evidence update A report commissioned by Public Health England. 2015; Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/733022\/Ecigarettes_an_evidence_update_A_report_commissioned_by_Public_Health_England_FINAL.pdf."},{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0269881112458731","article-title":"Reducing harm from tobacco use","volume":"27","author":"McNeill","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.crtox.2021.08.003_b0200","doi-asserted-by":"crossref","first-page":"e58966","DOI":"10.1371\/journal.pone.0058966","article-title":"Regulation of IL-17A Production Is Distinct from IL-17F in a Primary Human Cell Co-culture Model of T Cell-Mediated B Cell Activation","volume":"8","author":"Melton","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.crtox.2021.08.003_b0205","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1165\/ajrcmb.10.6.8003339","article-title":"Cell number and distribution in human and rat airways","volume":"10","author":"Mercer","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"11","key":"10.1016\/j.crtox.2021.08.003_b0210","doi-asserted-by":"crossref","first-page":"11325","DOI":"10.3390\/ijerph111111325","article-title":"Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols","volume":"11","author":"Misra","year":"2014","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"12","key":"10.1016\/j.crtox.2021.08.003_b0215","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/jdv.12846","article-title":"Smoking is associated with combined allergic and irritant hand eczema, contact allergies and hyperhidrosis","volume":"29","author":"Molin","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.crtox.2021.08.003_b0220","unstructured":"National Academies of Sciences, E., et al., in Using 21st Century Science to Improve Risk-Related Evaluations. 2017, National Academies Press (US) Copyright 2017 by the National Academy of Sciences. All rights reserved.: Washington (DC)."},{"issue":"6","key":"10.1016\/j.crtox.2021.08.003_b0225","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11739-019-02025-3","article-title":"A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers","volume":"14","author":"O\u2019Connell","year":"2019","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.crtox.2021.08.003_b0230","doi-asserted-by":"crossref","unstructured":"O'Mahony, A., et al., 2018, AB0050 Biomap\u00ae phenotypic profiling of two batches of originator etanercept reveals equivalent activity signatures consistent with conserved biological activity. Vol. 77. 1225.1-1225.","DOI":"10.1136\/annrheumdis-2018-eular.2335"},{"issue":"3","key":"10.1016\/j.crtox.2021.08.003_b0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/1354750X.2017.1419284","article-title":"Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products","volume":"23","author":"Peck","year":"2018","journal-title":"Biomarkers"},{"key":"10.1016\/j.crtox.2021.08.003_b0240","unstructured":"Plus, E.D. BioMAP Diversity PLUS Panel. 2021 [cited 2021 5th May]; Available from: https:\/\/www.eurofinsdiscoveryservices.com\/services\/phenotypic-assays\/biomap\/diversity-plus\/."},{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14043-2","article-title":"Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked","volume":"7","author":"Polosa","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.crtox.2021.08.003_b0250","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clinbiochem.2007.09.001","article-title":"Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes","volume":"41","author":"Postadzhiyan","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.crtox.2021.08.003_b0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.tox.2015.11.007","article-title":"Systems toxicology-based assessment of the candidate modified risk tobacco product THS2.2 for the adhesion of monocytic cells to human coronary arterial endothelial cells","volume":"339","author":"Poussin","year":"2016","journal-title":"Toxicology"},{"issue":"11","key":"10.1016\/j.crtox.2021.08.003_b0260","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/0960327116681653","article-title":"Investigation of solid particles in the mainstream aerosol of the Tobacco Heating System THS2.2 and mainstream smoke of a 3R4F reference cigarette","volume":"36","author":"Pratte","year":"2017","journal-title":"Hum. Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0265","doi-asserted-by":"crossref","first-page":"268","DOI":"10.18632\/oncotarget.13613","article-title":"Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?","volume":"8","author":"Qiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.crtox.2021.08.003_b0270","series-title":"The Chemical Components of Tobacco and Tobacco Smoke","author":"Rodgman","year":"2013"},{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0275","doi-asserted-by":"crossref","DOI":"10.1038\/srep08163","article-title":"Cigarette smoke alters primary human bronchial epithelial cell differentiation at the air-liquid interface","volume":"5","author":"Schamberger","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.crtox.2021.08.003_b0280","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.3390\/ijerph120403915","article-title":"Evaluation of E-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells","volume":"12","author":"Scheffler","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"9","key":"10.1016\/j.crtox.2021.08.003_b0285","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200140090-00003","article-title":"The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments","volume":"40","author":"Schneider","year":"2001","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.crtox.2021.08.003_b0290","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/tx020069f","article-title":"Acetaldehyde in mainstream tobacco smoke: formation and occurrence in smoke and bioavailability in the smoker","volume":"15","author":"Seeman","year":"2002","journal-title":"Chem. Res. Toxicol."},{"issue":"7","key":"10.1016\/j.crtox.2021.08.003_b0295","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.chembiol.2017.06.003","article-title":"Mechanisms of skin toxicity associated with metabotropic glutamate receptor 5 negative allosteric modulators","volume":"24","author":"Shah","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"8","key":"10.1016\/j.crtox.2021.08.003_b0300","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1289\/ehp.0800407","article-title":"Exposure as part of a systems approach for assessing risk","volume":"117","author":"Sheldon","year":"2009","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.crtox.2021.08.003_b0305","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.crtox.2020.11.001","article-title":"The use of human induced pluripotent stem cells to screen for developmental toxicity potential indicates reduced potential for non-combusted products, when compared to cigarettes","volume":"1","author":"Simms","year":"2020","journal-title":"Curr. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0310","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jat.4064","article-title":"Collecting e-cigarette aerosols for in vitro applications: a survey of the biomedical literature and opportunities to increase the value of submerged cell culture-based assessments","volume":"41","author":"Smart","year":"2021","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.crtox.2021.08.003_b0315","unstructured":"Standardization, I.O.f. ISO 20778:2018 Cigarettes \u2014 Routine analytical cigarette smoking machine \u2014 Definitions and standard conditions with an intense smoking regime. 2018 [cited 2020 15th September]; Available from: https:\/\/www.iso.org\/standard\/69065.html."},{"key":"10.1016\/j.crtox.2021.08.003_b0320","unstructured":"Standardization, I.O.f. ISO 20768:2018 Vapour products \u2014 Routine analytical vaping machine \u2014 Definitions and standard conditions. 2018 [cited 2020 15th September]; Available from: https:\/\/www.iso.org\/standard\/69019.html."},{"issue":"5","key":"10.1016\/j.crtox.2021.08.003_b0325","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/ijms19051442","article-title":"A new venue of TNF targeting","volume":"19","author":"Steeland","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0330","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1513\/pats.200407-038MS","article-title":"The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease","volume":"2","author":"Tapson","year":"2005","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0335","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13104-020-05337-2","article-title":"In vitro biological assessment of the stability of cigarette smoke aqueous aerosol extracts","volume":"13","author":"Taylor","year":"2020","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.crtox.2021.08.003_b0340","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.yrtph.2017.12.010","article-title":"Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting","volume":"92","author":"Walele","year":"2018","journal-title":"Regul. Toxicol. Pharm."},{"issue":"1","key":"10.1016\/j.crtox.2021.08.003_b0345","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41467-019-08887-7","article-title":"The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy","volume":"10","author":"Wang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crtox.2021.08.003_b0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tiv.2018.09.006","article-title":"Assessing bioactivity-exposure profiles of fruit and vegetable extracts in the BioMAP profiling system","volume":"54","author":"Wetmore","year":"2019","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.crtox.2021.08.003_b0355","unstructured":"WHO, 2019. WHO report on the global tobacco epidemic 2019: offer help to quit tobacco use. Available from: https:\/\/www.who.int\/teams\/health-promotion\/tobacco-control\/who-report-on-the-global-tobacco-epidemic-2019&publication=9789241516204."},{"issue":"suppl 3","key":"10.1016\/j.crtox.2021.08.003_b0360","doi-asserted-by":"crossref","first-page":"iii3","DOI":"10.1136\/tobaccocontrol-2014-051670","article-title":"Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation","volume":"23","author":"Zhu","year":"2014","journal-title":"Tob Control"}],"container-title":["Current Research in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666027X2100030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666027X2100030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T10:22:02Z","timestamp":1762942922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666027X2100030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":72,"alternative-id":["S2666027X2100030X"],"URL":"https:\/\/doi.org\/10.1016\/j.crtox.2021.08.003","relation":{},"ISSN":["2666-027X"],"issn-type":[{"value":"2666-027X","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of a rapid human primary cell-based disease screening model, to compare next generation products to combustible cigarettes","name":"articletitle","label":"Article Title"},{"value":"Current Research in Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crtox.2021.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}